Connection

ADEL K EL-NAGGAR to Extracellular Signal-Regulated MAP Kinases

This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Extracellular Signal-Regulated MAP Kinases.
  1. TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene. 2013 Aug 08; 32(32):3698-710.
    View in: PubMed
    Score: 0.022
  2. Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies. J Clin Endocrinol Metab. 2011 Apr; 96(4):997-1005.
    View in: PubMed
    Score: 0.020
  3. IQGAP1 plays an important role in the invasiveness of thyroid cancer. Clin Cancer Res. 2010 Dec 15; 16(24):6009-18.
    View in: PubMed
    Score: 0.019
  4. Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma. Head Neck. 2008 Aug; 30(8):991-1000.
    View in: PubMed
    Score: 0.017
  5. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. J Clin Endocrinol Metab. 2008 Aug; 93(8):3106-16.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.